Treatment of myelodysplastic syndromes with hemopoietic growth factors

Semin Oncol. 1992 Feb;19(1):106-14.

Author

P L Greenberg¹

Affiliation

¹ Division of Hematology, Stanford University School of Medicine, CA 94305.

PMID: 1371018

No abstract available

Publication types

Review

MeSH terms

Erythropoietin / therapeutic use*
Granulocyte Colony-Stimulating Factor / therapeutic use*
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Hematopoietic Cell Growth Factors / therapeutic use
Humans
Interleukin-3 / therapeutic use*
Myelodysplastic Syndromes / therapy*

Substances

Hematopoietic Cell Growth Factors
Interleukin-3
Erythropoietin
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor